Enzolytics Inc (ENZC)

[Jack Torrance]

Drugs don't come to market overnight, but even a substantial PR documenting that their Clone 3 is in fact 95% effective against HIV and can be tailored to other infectious diseases, and even possible some forms of Cancer and Multiple Sclerosis will propel this stock to a few buck on hype alone. Then, when this drug actually begins use in Europe and is FDA approved in the states, watch out. $10 plus easy. People need to temper their timeline expectations when it comes to biotech and pharma, though. These things NEVER happen as fast as you'd like.